Vendor, Monona, WI
Flambeau Diagnostics LLC
UEI VLZHU9Z7URH3, CAGE 8PXP5
1 award and $0 obligated between September 18, 2025 and September 22, 2025, 0% under full and open competition, against 1.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | $0 |
How it wins
Awards by competition, set-aside and type.
| Not Competed | 1 |
| Definitive Contract | 1 |
Hear when Flambeau Diagnostics LLC wins an award and when a contract it holds is about to end.Follow it
Contracts ending soon
None of Flambeau Diagnostics LLC's contracts with a published end date ends in the next 19 months.
Competes with
Vendors selling research and development in biotechnology (except nanobiotechnology) to National Institutes of Health, by dollars.
| Fisher Bioservices Inc.Rockville, MD | $101,554,099 |
| PPD Development LPWilmington, NC | $65,307,629 |
| Seattle Children'S HospitalSeattle, WA | $61,525,979 |
| Alpha Genesis Inc.Yemassee, SC | $55,645,143 |
| Psychogenics Inc.Paramus, NJ | $36,035,836 |
| Rho Federal Systems Division Inc.Durham, NC | $35,268,211 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N92021C00018Definitive Contract, September 18, 2025, Not Competed, 1 offers | National Institutes of Health NhlbiNational Institutes of Health | Ipp -Radx Tech 2375 - Point of Need, Saliva-Based, Covid-19 Testing PlatformsNAICS 541714, PSC Q301 | $0 |
- Places of performance
- Wisconsin
- Product and service codes
- Q301 Reference Laboratory Testing
- Transactions
- 2 across 1 awards